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Monitoring changes in gene expression in renal ischemia-reper- Acute renal failure (ARF), characterized by rapid de-
fusion in the rat. cline in glomerular filtration rate (GFR), is potentially
Background. Although acute renal failure (ARF) is a rela- reversible but is associated with major morbidity andtively common disorder with major morbidity and mortality,
mortality. Despite new insights into the pathogenesis ofits molecular basis remains incompletely defined. The present
ARF, neither the incidence nor mortality has declinedstudy examined global gene expression in the well-character-
ized ischemia-reperfusion model of ARF using DNA micro- in decades [1]. During the induction and course of ARF
array technology. many intrarenal alterations occur, including changes in
Methods. Male Wistar rats underwent bilateral renal isch- cell polarity [2–5], levels of signaling molecules [6–11]emia (30 min) or sham operation, followed by reperfusion for
expression of adhesion molecules [8, 12–15] and patterns1, 2, 3 or 4 days. Plasma creatinine increased approximately
of apoptosis and necrosis [16]. Nevertheless, it is proba-fivefold over baseline, peaking on day 1. Renal total RNA was
used to probe cDNA microarrays. ble that additional factors participate in the evolution
Results. Alterations in expression of 18 genes were identified and repair of ARF but are yet to be appreciated. Dis-
by microarray analysis. Nine genes were up-regulated (ADAM2,
covering such factors may lead to improved strategiesHO-1, UCP-2, and thymosin4 in the early phase and clusterin,
for preventing ARF and treating this serious disorder.vanin1, fibronectin, heat-responsive protein 12 and FK506
binding protein in the established phase), whereas another nine Certain changes seen in the course of ARF involve
were down-regulated (glutamine synthetase, cytochrome p450 infiltrating cells and adhesion molecules. Neutrophil in-
IId6, and cyp 2d9 in the early phase and cyp 4a14, Xist gene, filtration is induced by adhesion molecules such as inter-
PPAR, -albumin, uromodulin, and ADH B2 in the estab-
cellular adhesion molecule-1 (ICAM-1) and E-selectinlished phase). The identities of these 18 genes were sequence-
via the mediation of tumor necrosis factor- (TNF)verified. Changes in gene expression of ADAM2, cyp2d6, fi-
bronectin, HO-1 and PPAR were confirmed by quantitative and nuclear factor-B (NF-B). Infiltrating neutrophils
real-time polymerase chain reaction (PCR). ADAM2, cyp2d6, induce adhesion molecules such as integrins [12], E-selec-
and PPAR have not previously been known to be involved tin [13], P-selectin [14], intercellular adhesion molecule-in ARF.
1 [8], and neural cell adhesion molecule [15]. InhibitionConclusion. Using DNA microarray technology, we identi-
of NF-B using a decoy oligonucleotide has been re-fied changes in expression of 18 genes during renal ischemia-
reperfusion injury in the rat. We confirmed changes in five genes ported to suppress the inflammatory response that fol-
(fibronectin, ADAM2, cyp 2d6, HO-1 and PPAR) by quanti- lows ischemia-reperfusion injury [17]. Animals that ex-
tative real-time PCR. Several genes, not previously been identi-
press aberrant adhesion molecules may be protectedfied as playing a role in ischemic ARF, may have importance
from renal injury, as noted in ICAM-1–deficient micein this disease.
that are resistant to ischemic renal injury [18].
Depolarization of epithelial cells occurs in the course
of renal injury and repair, in part secondary to changes
in adhesion molecules. For example, in ARF induction
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cytoplasmic aggregates [19], which leads to depolariza-
tion and exfoliation of epithelial cells. Newly expressed
integrin appears to restore cell polarization, accompanied
by increased expression of laminin and fibronectin [19].
Ischemic injury results in apoptosis as well as necrosis.
Apoptosis is mediated through several signaling cas-
cades, one of which is the mitogen-activated protein
(MAP) kinase cascade. Members of this family, such as
p38MAPK [10], JNK and ERK [11] have been previously
reported to play a role in ARF. Park, Chen and Bonven-
tre suggested that activation of JNK or p38 is involved
in protection against ischemic injury in the kidney [11].
Fig. 1. Serum creatinine in sham-operated () and ischemia-reperfu-TNF- and integrin also have been reported to mediate
sion () rats at various times. Creatinine rose to a peak at 24 hours inapoptosis [20, 21]. the ischemia-reperfusion rats. Data are expressed as mean  SEM for
DNA microarray technology offers the advantage of 4 rats.
analyzing thousands of genes simultaneously, with the
potential to uncover new mechanisms of pathogenesis.
Thus, microarray analysis coupled with bioinformation
RNA from animals that showed more prominent creati-could detect changes in genes previously unknown to
nine changes. Animals were then followed for 1, 2, 3, orparticipate in renal injury and repair. Such an approach
4 days (at least N  3 per group per time point).could lead, potentially, to a new paradigm through which
At sacrifice the kidneys were removed and snap-frozenARF may be better understood. In the present study, we
in liquid nitrogen. The samples were stored at 70Cexamined changes in gene expression induced by ische-
until further study. The serum creatinine level over timemia-reperfusion injury. A total of 2,100 mouse cDNAs
is shown in Figure 1, and documents successful inductionspotted onto a glass slide were used for profiling gene ex-
of ARF. Total RNA was isolated from kidney by Trizolpression. As expected, we found that many of the changes
(Gibco, Rockville, MD, USA) extraction.in expression occur in genes that encode proteins pre-
viously implicated in ischemia-reperfusion injury. How-
High-density DNA microarray preparationever, and importantly, ADAM2 (a disintegrin domain
High-density cDNA microarrays were generated byand metalloproteinase), cytochrome p450 IID6, peroxi-
standard methods [22]: Mouse expressed sequence tagssome proliferator-activated receptor gamma (PPAR)
(ESTs; Research Genetics, Huntsville, AL, USA) werewere newly identified to participate in ARF.
amplified by the polymerase chain reaction (PCR), ac-
cording to the manufacturer’s recommendations. Each
METHODS sample was run in a 1% agarose gel for quality verifica-
Animals and RNA extraction tion (data not shown). The sizes of PCR products ranged
from approximately 300 bp to 1.2 kb. DNA microarrays,Male Wistar rats (200 to 250 g, N  16 ischemia-
containing 2,100 distinct ESTs, were printed onto glassreperfusion, N  20 sham) were housed in a 12-hour
slides using a pin-style arrayer (BioRobotics, Cambridge,light/dark cycle, and allowed free access to food and
UK). The identities of all 18 genes were confirmed bywater. Control and treated animals were weight- and
DNA sequencing using an ABI PRISM 377 DNA se-age-matched at the time of initiation of bilateral ischemic
quencer (Applied Biosystems, Foster City, CA, USA)injury, and body weights were recorded at initiation and
performed by the Genome Center staff at Brigham &completion of experiments. The animals were allowed
Women’s Hospital. The sequence was confirmed usingfree access to standard rodent chow and water until over-
BLAST (http://www.ncbi.nlm.nih.gov/BLAST/).night prior to surgery when food (but not water) was
To make microarrays, sialylated glass slides (CEL As-removed. Animals were anesthetized intraperitoneally
sociates Inc., Houston, TX, USA) were cleaned for twowith pentobarbital sodium, 65 mg/kg. Both renal arteries
hours in a solution of 2 N NaOH. After rinsing in distilledwere exposed using a midline incision and then clamped
water, the slides were treated with a 1:5 dilution of poly-for 30 minutes followed by reperfusion. Sham animals
l-lysine adhesive solution (Sigma, St. Louis, MO, USA)had an incision plus 30 minutes of waiting time without
for one hour, and then dried for five minutes at 80Cclamping. After ischemia or sham treatment, muscle
in a vacuum oven. DNA samples from 100-	L PCRlayer incisions were sutured, and skin incisions closed
reactions were precipitated with ethanol in 96-well mi-with Michel clips. We gave a total of 6 mL of 0.9% saline
crotiter plates. The resulting precipitates were resus-solution IP to the rats during and after surgery to prevent
dehydration. In the present study, we chose to analyze pended in 20 	L 3 
 standard sodium citrate (SSC; 20 
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SSC; 3.0 mol/L NaCl and 0.3 mol/L sodium citrate) and The cut off was based on at least twofold changes for the
transferred to new plates for arraying. After printing, genes of interest. The chips were scanned in a ScanArray
the microarrays were rehydrated for 10 seconds in a 5000 confocal laser scanner (GSI Lumonics, Marina Del
humidity chamber. The DNA was then ultraviolet-cross- Rey, CA, USA). The signal and background signals were
linked to the surface by subjecting the slides to 60 mJ then quantified with ImaGene 4.0 quantification software
of energy (Stratagene Stratalinker, La Jolla, CA, USA). (BioDiscovery, Billerica, MA, USA). Signals were mea-
Directly after the blocking reaction, the bound DNA sured as the mean pixel intensity within each circumscribed
was denatured by a two-minute incubation in distilled spot and average background was measured using the
water at 95C. The slides were then transferred into a mean pixel intensities of blank spots in the array (without
bath of 20C ethanol, rinsed, and then spun dry in a cDNA) and as the mean pixel intensity outside the circum-
clinical centrifuge. Slides were stored in a closed box at scribed spot diameter for calculating specific signals.
room temperature until used.
Quantitative real time PCR
cDNA probe labeling Quantitation with real-time, one-step reverse-tran-
cDNA probes were synthesized as previously reported scriptase polymerase chain reaction (RT-PCR) was per-
[23] to improve signal detection on high-density micro- formed with SYBR Green PCR Reagents and an ABI
arrays using a fluorescent oligonucleotide dendrimeric PRISM 7700 Sequence Detection System (PE Applied
signal amplification system. Briefly, 10 	g of total RNA Biosystems, Foster City, CA, USA), according to the
was primed with 1.0 picomole of modified reverse tran- manufacturer’s instructions. Reactions were performed
scription (RT) primer with capture sequence for Cy3 or using 1.0 	L of RNA at a concentration of 100 ng/	L,
Cy5 (Genisphere, Montvale, NJ, USA). The RT reaction in a reaction volume of 50 	L. An RT reaction was
was performed according to standard protocols (Super- performed at 48C for 30 minutes, followed by PCR
Script RT II; Gibco), followed by the addition of 3.5 	L consisting of AmpliTaq activation for 10 minutes at 95C,
of 0.5 mol/L NaOH/50 mmol/L ethylenediaminetetra- then 40 cycles with heating to 95C for 15 seconds, and
acetic acid (EDTA), and heating at 65C for ten minutes cooling to 60C for one min. mRNA levels were normal-
to denature the DNA/RNA hybrids. This reaction was ized to levels of glyceraldehyde-3-phosphate dehydroge-
then neutralized with 5 	L of 1 mol/L Tris, pH 7.5. For nase (GAPDH). We elected to confirm changes in five
double-labeled detection, RT reactions were mixed and genes using real-time one-step quantitative RT-PCR.
precipitated using 3 mol/L sodium acetate and 100% These five genes and PCR primers are as follows:
ethanol, then washed once with 70% ethanol. The pellets
Fibronectin.
were resuspended in 20 	L distilled H2O. Forward primer, 5-GTGGCTGCCTTCAACTTCTC-3
Reverse primer, 5-GTGGGTTGCAAACCTTCAAT-3Hybridization
HO-1.cDNA microarrays were prehybridized with 500 	L of
Forward primer, 5-TCTATCGTGCTCGCATGAAC-3preheated (65C) ExpressHyb (Clontech, Palo Alto, CA,
Reverse primer, 5-CAGCTCCTCAAACAGCTCAA-3USA) for an hour in a microarray hybridization chamber
ADAM2.(Grace Bio-Labs, Bend, OR, USA) in a rotisserie hybrid-
Forward primer, 5-GGGATCTGTTTGGCACTGAT-3ization oven. Probe was put into the hybridization cham-
Reverse primer, 5-ATTAGGTGCGCAGTCCTTGT-3ber and incubated overnight in a rotisserie hybridization
PPAR.oven. The next day the microarrays were washed for five
Forward primer, 5-TGTGGACCTCTCTGTGATGG-3minutes in 2 
 SSC/0.2% sodium dodecyl sulfate (SDS)
Reverse primer, 5-CATTGGGTCAGCTCTTGTGA-3at 65C, then in 2 
 SSC and 0.2 
 SSC for two minutes
Cytochrome P450 IId6.each. For dendrimer detection, 1.0 	L of the Cy3- and
Forward primer, 5-AGCTTCAACACCGCTATGGT-3Cy5-labeled dendrimers (Genisphere) were suspended
Reverse primer, 5-CAGCAGTGTCCTCTCCATGA-3in 15 	L of 4 
 SSC/2% SDS and layered on the array.
GAPDH.The arrays were covered with a coverslip and then incu-
Forward primer, 5-ACTCCCATTCCTCCACCTTT-3bated at 65C for eight hours in a microarray hybridiza-
Reverse primer, 5-TTACTCCTTGGAGGCCATGT-3tion cassette (Telechem International, Sunnyvale, CA,
All primer sets were designed according to manufac-USA). The chips were then washed as above.
turer’s recommendations, and when feasible, to span one
Data collection, normalization, and analysis or more introns. All amplicons ranged between 142 and
148 base pairs. Electrophoretic analysis of expectedEach time point was analyzed twice with reverse color
product sizes was performed for all primer sets prior tolabeling. The mean of the two measurements was used
one step, real time RT-PCR, to confirm the fidelity ofto determine the fold changes. As was stated, dye rever-
sal was used. This analysis uses a log-normal error model. the reaction.
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RESULTS days, consistent with other reports [12, 25]. ADAM2 was
up-regulated by 3.3 fold and gradually normalized.cDNA microarray analysis
Representative differential expression patterns are Genes down-regulated by ischemia-reperfusion injury
shown for sham (Fig. 2A) and ischemia-reperfusion sam-
Figure 5 shows nine genes that were decreased in IR.
ples (Fig. 2B) at day 1 on one glass slide. Ischemia-reper-
Of these nine, four genes decreased acutely, including
fusion (IR) samples were labeled with Cy3 and sham
alpha-albumin protein, cytochrome P450 IID6 (cyp2d6),
with Cy5. This figure demonstrates clear signals with cytochrome P450 IId9 (cyp2d9), and glutamine synthe-
little background and several instances of clear differen- tase (Fig. 5A). Cyp2d6 was markedly decreased, to ap-
tial gene expression. Every spot is well rounded and has proximately 20% of the sham value.
virtually the same diameter. Figure 2C shows an overlay Five genes were chronically down-regulated, includ-
picture of sham and IR such that green spots indicate ing alcohol dehydrogenase-B2, cytochrome P450 IVa14
up-regulation and red spots indicate down-regulation, (cyp4a14), PPAR, Xist gene, and uromodulin (Fig. 5B).
and yellow spots indicate no change, respectively. The Uromodulin was decreased to approximately 20 to 25%
numbers 1, 2, 3, 4, and 5 indicate clusterin, ADAM2, of the sham value.
HO-1, cyp2d6, PPAR, respectively. Of these, clusterin,
ADAM2, and HO-1 are increased and cyp2d6 and PPAR Confirmation of change in expression
are decreased in IR. Microarray data of five genes of interest were con-
As shown in Figure 3A, a scatter plot of sham (Cy3) firmed by real-time quantitative PCR (Fig. 6); others
versus sham (Cy5) fell on a line of identity. When a scat- were not tested. Fibronectin was chosen because of its
ter plot of sham (Cy5) versus IR (Cy3) was performed, well-known increase in ischemic injury [12]. HO-1 was
some changes in individual genes were seen (Fig. 3B). selected as increased on gene array and previously de-
Red spots, (identified as Adam2, HO-1, and clusterin) scribed to be increased in ARF [24, 26–28]. ADAM2
signify up-regulated genes in IR and green spots (identi- was chosen as a gene that was increased on gene array,
fied as cyp2d6 and PPAR) signify down-regulated genes. and a previously undescribed finding in ARF. PPAR
To confirm these data, reverse labeling was performed. and Cyp 2d6 were chosen as they were decreased on
Instead of labeling IR with Cy3 and sham with Cy5, IR gene array, previously undescribed findings in ARF. Us-
was labeled with Cy5 and sham with Cy3. In Figure 3C, ing real-time PCR, HO-1 and ADAM 2 were confirmed
a scatter plot of this reverse labeling is shown; now green to be transitionally increased whereas cytochrome p450
spots (identified as Adam2, HO-1, and clusterin) signify IId6 and PPAR were decreased in ischemia-reperfu-
genes decreased in IR and red spots (identified as cyp2d6 sion. Thus, there was excellent concordance between
and PPAR) signify transcripts increased in IR. Thus, microarray data and real time PCR, though the magni-
these reverse labeling experiments demonstrated consis- tude of changes were more pronounced than those seen
tent results. Furthermore, all 18 transcripts altered were with microarray analysis.
sequence-verified to confirm their identities.
Genes up-regulated by ischemia-reperfusion injury DISCUSSION
Figure 4 shows the nine genes increased in IR. Of these, In the present study, we demonstrated that multiple
three increased acutely. These include heme oxygenase-1, gene transcripts were increased or decreased by isch-
thymosin 4, and uncoupling protein (UCP)-2 (Fig. 4A). emia-reperfusion, and we identified several genes pre-
Heme oxygenase-1 (HO-1) increased at day 1 followed viously unknown to be involved in renal injury and re-
by normalization, a finding previously reported in a rat pair. For example, it has been previously reported that
model of ARF [24]. Thymosin 4 (Tb4) increased ap- clusterin [16] and fibronectin [12, 29] are up-regulated
proximately twofold. Uncoupling protein (UCP)-2 mRNA by renal ischemia-reperfusion injury, and that HO-1 is
level increased by 2.8-fold at day 1 and recovered to up-regulated during ARF [24, 30, 31]. Uromodulin has
baseline at day 4. previously been shown to decrease after renal ischemia-
Six genes were elevated throughout the four-day time reperfusion injury [32].
course of IR (Fig. 4B). These included ADAM2, clus- The transcript with the largest observed change was
terin, FK506 binding protein 1a (Fkbp1a), fibronectin, clusterin, known as a marker for cell injury in the tissues.
vanin1, and heat-responsive protein 12 (hrsp12). The ex- In the present studies clusterin was increased from day 1
pression of clusterin (also known as a TRPM-2 or sul- to day 4 after ischemic injury. Clusterin mRNA is overex-
fated glycoprotein 2) was increased approximately five- pressed in apoptosis-resistant cells [33] and is required
fold and maintained at that level until day 4. Fibronectin for survival of cells treated with TNF or subjected to
oxidative stress [34–36]. Thus, we infer from these find-increased by about 2.5 fold and remained so for four
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Fig. 2. Representative differential expression by cDNA array. Representative differential expression is shown by microarray of sham (A, Cy3)
and ischemia-reperfusion (B, Cy5) at day 1 on one glass slide. (C ) Overlay picture of sham and IR microarray is shown. In this picture, each red
spot indicates higher signal in sham and each green spot indicates higher in IR. Numbers denote: (1) clusterin, (2) ADAM2, (3) HO-1, (4) cyp2d6,
(5) PPAR. Note that the signal of spots numbered 1, 2 and 3 are higher on the right compared to the left, indicating an increase. In contrast,
the spots numbered 4 and 5 indicate a decrease in expression.
Fig. 3. Scatter plot graph of microarray data.
(A) Sham labeled by Cy3 versus sham labeled
by Cy5. All data points are on a 45 angle,
confirming the accuracy of this technique. (B)
Scatter plot of sham labeled by Cy5 versus is-
chemia-reperfusion (IR) labeled by Cy3 at day
1 was shown. Red spots, (typed as ADAM2,
HO-1, and clusterin) signify genes that are up-
regulated and green spots, (typed as cyp2d6
and PPAR) signify genes that are down-reg-
ulated. (C ) Scatter plot of IR labeled by Cy5
vs sham labeled by Cy3 as shown on day 1, as
a reverse labeling of scatter plot B. Red spots,
(typed as ADAM2, HO-1, and clusterin) sig-
nify up-regulated and green spots, (typed as
cyp2d6 and PPAR), down-regulated. Thus,
reverse labeling confirmed the data. Abbrevi-
ations are: ADAM2, a disintegrin domain and
metalloproteinase; Clu, clusterin; HO1, heme
oxygenase-1; Cyp2d6, cytochrome P450 2d6;
PPAR, peroxisome proliferator activated
receptor-gamma.
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Fig. 5. Time course of down-regulated genes. Relative fold change of
ischemia-reperfusion/sham is shown in time-dependent manner. Abbre-
viations are: IR; ischemia-reperfusion; Aalb, alpha-albumin protein;
Adhb2, alcohol dehydrogenase-B2; Cyp2d6, cytochrome P450 2d6;Fig. 4. Time course of up-regulated genes. The relative fold change
Cyp2d9, cytochrome P450 2d9; Cyp4a14, cytochrome P450, 4a14of ischemia-reperfusion/sham is shown in a time-dependent manner.
(Cyp4a14); PPAR, peroxisome proliferator activated receptor gamma;Abbreviations are: IR, ischemia-reperfusion; ADAM2, a disintegrin do-
Glns-ps1, intronless glutamine synthetase gene; Xist, Xist gene, P0main and metalloproteinase; Clu, clusterin; Fkbp1a, FK506 binding
region; Umod, uromodulin. Symbols in A are: () Adhb2; () Cyp4a14;protein 1a; Fn, fibronectin; HO1, heme oxygenase-1; Hrsp12, heat-
() PPAR; () Xist; () Umod. Symbols in B are: () Aalb; ()responsive protein 12; Tmsb4, thymosin beta-4; Ucp2, UCP2; Vnn1,
Cyp2d6; () Cyp2d9; () Glns-ps1.vanin 1. Symbols in A are: () HO1; () Tmsb4; () Ucp2. Symbols
in B are: () Adam2; () Clu; () Fkbp1a; () FN; () Vnn1; ()
Hrsp12.
the thick ascending limb of Henle’s loop [37]. Safirstein et
al and Bachmann et al reported that uromodulin mRNA
ings that clusterin may play role in protection from isch- declined to undetectable levels by 24 hours after renal
emia-induced apoptosis in kidney. ischemia-reperfusion [32, 37]. We confirm their observa-
In the present study, HO-1 increased at day 1, de- tion on day 1 after ischemia injury. In addition, our data
creased gradually at day 2 and normalized by day 4. show that uromodulin gene expression was continuously
HO-1 has already been shown to be increased in the inhibited up to day 4 post-injury.
kidney in various models of ARF [24, 26–28]. Shimizu The microarray data showed that ADAM2 was in-
et al reported that HO-1 conferred a protective effect creased on day 1 after IR injury and gradually returned
in ischemic acute renal failure, in that when HO activity to normal on day 4. The real-time PCR confirmed that
was blocked by tin mesoporphyrin, increases in micro- there is an increase of ADAM2 on day 1. However, the
somal heme concentration, and serum creatinine concen- PCR results further showed no changes or decrease after
tration were observed, along with extensive tubular epi- day 2. We do not know the reasons for this discrepancy.
thelial cell injury [31]. Nevertheless, the PCR results did confirm that ADAM2
Uromodulin (Tamm-Horsfall protein) was greatly de- was transiently up-regulated on day 1. Novel observa-
creased in our model. This protein, one of the most tions included increased ADAM2 in ARF. This gene,
also known as fertilin beta, is a well-characterized mole-abundant in the renal tubule, is exclusively localized to
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in re-polarization of renal tubular epithelial cells after
IR injury.
UCP-2 was increased by IR injury, a previously unre-
ported finding. This gene is involved in mitochondrial
hydrogen peroxide generation [48]. UCP-2 mRNA has
been reported to be up-regulated approximately three-
fold in fatty liver, during which hydrogen peroxide pro-
duction by mitochondria was increased. It has been
speculated that this increase may result from chronic
apoptotic stress and may play a role in adaptation to
such stress [49]. Li et al reported that UCP-2 is involved
in cellular defense against oxidative stress (hydrogen
peroxide 200 mmol/L) in clonal beta-cells that over-
express UCP-2 [50], further supporting this theory. We
speculate that UCP-2 plays an analogous role in renal
Fig. 6. Time course of relative fold change of mRNA by real-time
injury.quantitative polymerase chain reaction (PCR). Relative fold change of
ischemia-reperfusion/sham is shown in time-dependent manner. Abbre- Vanin-1 increased by about 2.7-fold and remained ele-
viations are: IR, ischemia-reperfusion; ADAM2, a disintegrin domain vated throughout the study period. Vanin-1, also called
and metalloproteinase; Cyp2d6, cytochrome P450 2d6; Fn, fibronectin;
pantetheinase, hydrolyzes pantethein to cysteamine (aHO1, heme oxygenase-1; PPAR, peroxisome proliferator activated
receptor gamma. Symbols are: () Adam2; () Cyp2d6; () FN; () powerful antioxidant) and pantothenic acid [51]. There-
HO-1; () PPAR. The values are expressed by log 2. Data are ex- fore, we hypothesize that vanin-1 acts as an endogenous
pressed as mean  SEM; N  4.
anti-oxidant in renal repair after ischemia-reperfusion
injury [52].
We noted PPAR to be down-regulated in ischemia-
reperfusion injury, a novel finding. PPARs (peroxisomecule that mediates cell-cell communication in sperm-egg
proliferator-activated receptors), a family of transcrip-interactions. ADAM2 has not previously been known
tion factors, have multiple roles that are of great interest.to be involved in ARF. Interestingly, this protein in-
Although etomoxir, a PPAR agonist, was reported tocreases in the central nervous system in cases of Alzhei-
protect the kidney in ischemia-reperfusion injury [53],mer’s disease, along with alteration in cell-matrix contact
to our knowledge the present work is the first to findin the brain [38]. We thus infer that this molecule plays a
changes in PPAR in this model. PPAR is a nuclearrole in cell-matrix interactions within the kidney. Several
receptor that serves as a transcription factor and thusmembers of the ADAM family have the ability to cleave
regulates several physiologic pathways, particularlytransmembrane proteins, such as growth factors, as well
those involved in lipid metabolism [54]. Fahmi reportedas their receptors, cell adhesion molecules, and cytokines,
that PPAR inhibited interleukin-1 induced matrix met-resulting in soluble forms of those substances, a phenom-
alloproteinase 13 [54]. Furthermore, Yee et al reportedenon that is termed ectodomain shedding [39]. For exam-
that the stromelysin-1 (MMP-3) gene, which is involvedple, ADAM-17 (TNF converting enzyme, TACE), a
in tissue remodeling, contains a PPAR element in itsmember of this family, cleaves transmembrane pro-
promotor [55]. Therefore, it seems likely that PPAR
TNF to produce mature form of TNF. Tissue inhibitor
plays a role in tissue repair, especially in control of MMP.
of metalloproteases-3 (TIMP-3) inhibits these proteins Nakajima et al observed that heterozygous PPAR-de-
that are involved in ectodomain shedding [40–43]. It may ficient mice subjected to intestinal ischemia suffered more
be that ADAM2 plays a role as a shedder, during the pronounced injury than control mice [56]. Furthermore,
regeneration needed during tissue repair after renal dam- when such mice were treated with a PPAR-activating
age. Thus, we speculate that ADAM2 plays an important ligand, BRL-49653, they were partially reconstituted and
role in repair after tissue injury with in the kidney. suffered less damage. This report supports our hypothesis
We also noted that thymosin 4 (Tb4) was increased that PPAR may act through one of its pathways related
in ischemia-reperfusion injury. The beta-thymosins con- to apoptosis and/or tissue repair after ischemic injury.
stitute a family of actin monomer-sequestering proteins Cytochrome p450 IId6, IId9, and IVa14, all of which
widely distributed among vertebrates, and Tb4 is most are involved with oxidation, were suppressed. When these
abundant protein in this family. Tb4 has been reported enzymes are active, they lead to consumption of oxygen.
to bind to actin monomers and to enhance wound healing Hence, when tissue is subjected to severe ischemic injury,
[44–46]. Additionally, it is up-regulated following focal these enzymes are likely suppressed in an attempt to
brain ischemia [47]. Our findings lead us to hypothesize minimize ischemic injury. We speculate that these en-
zymes are suppressed during ischemic renal injury in anthat Tb4 has a general role in repair of cytoskeleton and
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mediated inhibition of renal injury and neutrophil adhesion. Amattempt to minimize oxidation injury. Suppression of
J Physiol (Renal Physiol) 279:F809–F818, 2000
these cytochrome p450s may occur during the ischemic 9. Sakai M, Tsukada T, Harris RC: Oxidant stress activates AP-1
state to slow down oxidative metabolism, which would and heparin-binding epidermal growth factor-like growth factor
transcription in renal epithelial cells. Exp Nephrol 9:28–39, 2001lead to cytoprotection.
10. Faccio L, Chen A, Fusco C, et al: Mxi2, a splice variant of p38The present analysis of the global gene expression stress-activated kinase, is a distal nephron protein regulated with
profile in ischemia-reperfusion used whole kidney. Thus, kidney ischemia. Am J Physiol (Cell Physiol) 278:C781–C790, 2000
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